Pyrvinium pamoate is a classic anthelmintic agent for enterobiasis that has regained interest as a potential anticancer compound. It functions by inhibiting the Wnt/beta-catenin signaling pathway, demonstrating activity in both in vitro cellular assays and in vivo animal models of colorectal and other cancers.
